Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q2 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $6 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2024 revenue of ~$27 million, versus the consensus of $27.06 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.